Hyper-Elevated CK in Viral Myositis

Diagnostic Considerations

The American Society of Clinical Oncology notes that polymyalgia-like syndromes are distinguished from viral myositis by normal CK levels, despite patients experiencing pain but not true weakness 1
The European Society for Medical Oncology guidelines suggest that immune-mediated necrotizing myopathy (IMNM) can present with CK elevations greater than 10 times the upper limit of normal, requiring autoantibody testing and clinical context to differentiate from viral myositis 2
The American College of Cardiology recommends considering drug-induced myositis, such as immune checkpoint inhibitor-related myositis, which shows markedly elevated CK in over 80% of cases, with a median exposure time of 4 weeks 3

The American Academy of Neurology suggests measuring multiple muscle enzymes (CK, AST, ALT, LDH, aldolase) as one may be elevated when CK is normal or only mildly elevated 2
The European Society for Medical Oncology guidelines recommend obtaining myositis-associated autoantibodies, MRI, and electromyography to exclude immune-mediated causes 3
The American Heart Association advises assessing for cardiac involvement with troponin levels, as myocarditis can complicate severe myositis 3